Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 88.3B | 83.2B | 80.0B | 78.9B |
Cost of revenue | 19.2B | 19.0B | 19.9B | 18.7B |
Gross profit | 69.1B | 64.2B | 60.1B | 60.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 31.4B | 28.8B | 28.3B | 29.3B |
Operating income | 38.1B | 35.9B | 32.5B | 31.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 2.5B | 2.9B | 3.0B | 2.6B |
Other income expense | — | — | — | — |
Pretax income | 37.8B | 35.3B | 31.3B | 31.1B |
Tax provision | 7.8B | 8.5B | 8.0B | 7.7B |
Net income | 30.0B | 26.8B | 23.3B | 23.5B |
Basic EPS | — | 6.3 | 551 | 5.6 |
Diluted EPS | — | 6.3 | 5.5 | 5.6 |
Basic average shares | — | 4.2B | 4.2B | 4.2B |
Diluted average shares | — | 4.2B | 4.2B | 4.2B |
EBITDA | 40.3B | 38.1B | 35.2B | 33.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |